Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning

JAMA Psychiatry. 2019 Nov 1;76(11):1208-1210. doi: 10.1001/jamapsychiatry.2019.2563.

Abstract

This case series study provides a national estimate of opioid and benzodiazepine coprescribing before and after the US Food and Drug Administration (FDA) boxed warning.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid / therapeutic use*
  • Benzodiazepines / therapeutic use*
  • Drug Labeling*
  • Drug Overdose / prevention & control
  • Drug Prescriptions*
  • Humans
  • Practice Patterns, Physicians' / trends*
  • United States
  • United States Food and Drug Administration*

Substances

  • Analgesics, Opioid
  • Benzodiazepines